Yao Liu , PhD

Post-Doctoral Fellow

Yao received her Ph.D in Medicinal chemistry from Jilin University in 2008. During her Ph.D she focused on structural-design and synthesis of small molecule HIV entry inhibitors. Prior to joining DFCI, she was the senior research scientist at Chempartner, where she was involved in several research collaboration projects with Eli Lily, Epizyme and Novartis as key member. Yao joined the Gray lab in 2016 and is currently working on the development of inhibitors targeting YAP, CDK and JNK.